Solventum (SOLV) 10-K Summaries & Annual Filing History
Review Solventum Corporation (SOLV) 10-K filings from 2023 through the latest annual report, including business, financial performance, risks, and liquidity.
Key takeaway
Year ended Dec 31, 2025 · FY2025 10-K
Solventum Corporation filed its annual report covering the most recent fiscal year. The filing details the company's business, financial results, risk factors, and liquidity position.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$8.3B
Revenue reported for the fiscal year.
Operating income
$2.2B
Income from operations reported for the year.
Net income
$1.6B
Net income reported for the year.
Operating cash flow
$369M
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $8.1B | n/a |
| Dec 31, 2023 | $8.2B | +0.8% |
| Dec 31, 2024 | $8.3B | +0.7% |
| Dec 31, 2025 | $8.3B | +0.9% |
Business overview
Solventum Corporation operates in the healthcare and industrial sectors, providing a range of products and services. The company's business overview section outlines its operational segments and market focus. No further operational details are provided in the supplied context beyond the segment references.
Financial performance
The company reported revenue, operating income, and net income for the period. Operating cash flow was also disclosed. The filing indicates a stable revenue trend over recent periods, with modest changes in annual revenue.
Material risks
The risk factors section in the filing discusses potential challenges that may affect the company's operations and financial condition. Specific risks include unresolved staff comments and cybersecurity matters, as indicated in the filing table of contents. No further detail on individual risks is available in the supplied context.
Liquidity and capital
The management discussion and analysis section addresses financial condition and liquidity, including a review of capital resources. No specific capital allocation actions or plans are described in the supplied context beyond general liquidity management.
What to watch
The outcome of the unresolved staff comments identified in the filing should be monitored in the next periodic report.